INT50019

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.20
First Reported 1993
Last Reported 2003
Negated 2
Speculated 1
Reported most in Abstract
Documents 3
Total Number 3
Disease Relevance 0
Pain Relevance 0.55

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

peptidase activity (Ctrc)
Ctrc (Rattus norvegicus)
Pain Link Frequency Relevance Heat
Opioid 1 92.24 High High
tetrodotoxin 2 86.40 High High
Nicotine 7 84.36 Quite High
Nerve growth factor 1 83.60 Quite High
Hippocampus 4 5.00 Very Low Very Low Very Low
Neurotransmitter 2 5.00 Very Low Very Low Very Low
Glutamate 1 5.00 Very Low Very Low Very Low
isoflurane 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Learning Disorders 1 48.08 Quite Low
Dementia 1 46.48 Quite Low
Neurological Disease 3 5.00 Very Low Very Low Very Low
Neurodegenerative Disease 2 5.00 Very Low Very Low Very Low
Decapitation 1 5.00 Very Low Very Low Very Low
Cognitive Disorder 1 5.00 Very Low Very Low Very Low
Aging 1 5.00 Very Low Very Low Very Low
Disease 1 5.00 Very Low Very Low Very Low
Stroke 1 5.00 Very Low Very Low Very Low
Shock 1 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Residual responses after NO synthase inhibitors or after alpha-chymotrypsin were further reduced by pretreatment with alpha-chymotrypsin or NO synthase inhibitors, respectively.
alpha-chymotrypsin Neg (NO) Binding (pretreatment) of
1) Confidence 0.20 Published 1995 Journal Can. J. Physiol. Pharmacol. Section Abstract Doc Link 7600457 Disease Relevance 0 Pain Relevance 0.08
However, since they were not abolished by a combination of L-NAME and chymotrypsin, it appears that at least one more as yet unidentified mediator may be involved.
chymotrypsin Binding (combination) of
2) Confidence 0.19 Published 1993 Journal Clin. Exp. Pharmacol. Physiol. Section Abstract Doc Link 8339469 Disease Relevance 0 Pain Relevance 0.33
Similarity search has revealed that PEBP might be a serine protease inhibitor which inhibits thrombin, neuropsin and chymotrypsin but not trypsin, tissue type plasminogen activator and elastase.
chymotrypsin Neg (not) Spec (might) Binding (thrombin) of
3) Confidence 0.02 Published 2003 Journal Proteome Sci Section Body Doc Link PMC165415 Disease Relevance 0 Pain Relevance 0.13

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox